Illumina Posts Preliminary Q1 Revenues of $270M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina today reported preliminary first-quarter revenues of $270 million, down more than 4 percent compared to the first quarter of 2011 but above Wall Street's consensus estimate of $257.4 million.

The company, which plans to formally report first-quarter results later this month, added that it expects non-GAAP earnings per share for the first quarter to be "at or above current consensus estimates."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.